Cargando…
CD44-Targeted Nanocarrier for Cancer Therapy
Cluster of differentiation 44 (CD44) is a cell surface glycoprotein overexpressed in varieties of solid tumors including pancreatic, breast, ovary, brain, and lung cancers. It is a multi-structural glycoprotein of the cell surface which is majorly involved in cell proliferation, cell-to-cell interac...
Autores principales: | Kesharwani, Prashant, Chadar, Rahul, Sheikh, Afsana, Rizg, Waleed Y., Safhi, Awaji Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008230/ https://www.ncbi.nlm.nih.gov/pubmed/35431911 http://dx.doi.org/10.3389/fphar.2021.800481 |
Ejemplares similares
-
Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer
por: Fatima, Mahak, et al.
Publicado: (2022) -
Recent Progress of RGD Modified Liposomes as Multistage Rocket Against Cancer
por: Sheikh, Afsana, et al.
Publicado: (2022) -
The use of lipid-based nanocarriers for targeted pain therapies
por: Hua, Susan, et al.
Publicado: (2013) -
Three-Dimensional (3D) Printing in Cancer Therapy and Diagnostics: Current Status and Future Perspectives
por: Safhi, Awaji Y.
Publicado: (2022) -
Development of a Hyaluronic Acid-Based Nanocarrier Incorporating Doxorubicin and Cisplatin as a pH-Sensitive and CD44-Targeted Anti-Breast Cancer Drug Delivery System
por: Yu, Tao, et al.
Publicado: (2020)